Time |
Room No. |
Friday
08/07/2009 |
Saturday
08/08/2009 |
Sunday
08/09/2009 |
Monday
08/10/2009 |
Tech tour
08/11-08/12/2009 |
08:30
|
12:10 |
1 |
Registration
(All Day) |
OpeningCeremony
&
Keynote Forum |
Track 1-3:
Disease Genes for Drug Discovery and Development |
Track 6-9:
Cancer Cell Therapy |
Tech Tour
Beijing |
Track 1-4:
Molecular Genetics, Genomics & Epigenetics of Diseases |
Track 6-10:
Cytokine Therapy |
2 |
Track 2-3:
Nanoparticles for Diagnostics and Manufacturing |
Track 7-3:
Antibodies as Immunodiagnostic Markers |
Track 2-4:
Nanopartical System for Drug Delivery |
Track 7-4:
DNA Vaccine
R & D |
3 |
Track 3-3:
Molecular Diagnostics & Biomarkers |
Track 7-5:
AIDS, TB, Malaria and Emerging Disease Vaccine |
Track 3-4:
Cancer Molecular Diagnostics (I) |
Track 8-3:
Biopharmaceutical Processing-Proteins, Antibodies and Vaccines |
4 |
Track 4-3:
Predictive in silico and Computational Drug Discovery |
Track 8-4:
Bioprocesses for DNA and RNA Based Drugs; Antisense, microRNA and siRNA |
Track 4-4:
Computer Aided Drug Design and Algorithms, models, software, tools in Bioinformatics |
Track 8-5:
Biopharmaceutical Recovery & Purification with Improved QA/QC |
5 |
Track 5-3:
RNAi, mRNA, siRNA Technologies: From Drug Target Discovery to Validation (II) |
Track 9-1:
Opportunities & Challenges of Bio-Venture In China |
Track 5-4:
Delivery Technologies for Small RNAs |
Track 9-2:
From Biomedicine R & D to Industrialization in China |
6 |
Track 6-3:
Tumor Immunology and Immunotherapy |
|
Track 6-4:
Targeted Cancer Therapy |
|
12:10
|
13:30 |
Luncheon |
13:30
|
17:10 |
1 |
|
Track 1-1:
Functional Genomics Advances in Medicine |
Track 1-5:
Pharmcogenomics, Personalized Medicine and Therapeutics |
Tech Tour
Dalian |
Tech Tour
Beijing |
Track 1-2:
Proteomics and Medical Implications |
Track 1-6 :
Translational Medicine in Clinical Trials |
2 |
Track 2-1:
Frontier of Nanobiotechnologies |
Track 7-1:
Current and Emerging Antibody and Related Technologies |
Track 2-2:
Novel and Biocompatible Biomaterials in Biomedicine |
Track 7-2:
Therapeutic Monoclonal Antibody Discovery and Development |
3 |
Track 3-1:
Biochips for Molecular Diagnostics: From Gene chips, Microarray to Tissue Chips |
Track 3-5:
Cancer Molecular Diagnostics (II) |
Track 3-2:
Functional Genomics, NA Testing, PCR and Other Frontier Technologies |
Track 5-5:
RNAi, mRNA Therapeutics Development |
4 |
Track 4-1:
Bioinformatics, Informatics and Biostatistics in Biomedicine |
Track 8-1:
Cell Culture & Strain Screening Technology |
Track 4-2:
Clinical and Medical Informatics |
Track 8-2:
New Biotherapeutics Scaling Up Process or Method Development |
5 |
|
Track 5-1:
RNAi Biology & Technology Platform |
Track 6-5:
Tumor Vaccines |
Track 5-2:
RNAi, mRNA, siRNA Technologies: From Drug Target Discovery to Validation (I) |
Track 6-6:
Anticancer Monoclonal Antibodies |
6 |
Track 6-1:
Cell Biology in Oncology |
Track 6-7:
Molecular Oncology |
Track 6-2:
Novel Molecular Targets and Biomarkers to Cancer |
Track 6-8:
Cancer Gene Therapy |
